Genomic technologies and Optimum Heart Care The state of genomic knowledge of CVDs and stroke has expanded dramatically in recent years. Since our scientific statement was published in 2007, there has been rapid evolution of the genomic technologies, enabling a proliferation of GWASs investigating common, complex diseases, including CVDs and stroke. Because the number ofContinue reading “Personalized pharmacogenetic tests for cardio drugs”